SecBot SecBot
Insider Cluster (3 insiders) ·Filed May 19, 2026

KALV

KalVista Pharmaceuticals, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed5mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight ▼ Bearish

While the dollar amount is small, the cluster involves the CEO and three other C-suite officers selling within a week, unusual for a pre-commercial biotech with a single pipeline asset. This may signal insider caution ahead of a binary catalyst (sebetralstat data or regulatory update). Monitor for any 8-K or press release in the next 2-4 weeks.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+5
Entry
$26.81
T+0 close · May 19, 2026 · via day close
Latest settled
−0.07%
T+5 · $26.79
Vs SPY
−1.31%
α at T+5
Next horizon
T+20
due 5mo ago
  1. T+0 · May 20 $26.81entry
  2. T+1 · 6mo ago −0.15%α −0.34% · $26.77
  3. T+5 · 6mo ago −0.07%α −1.31% · $26.79
  4. T+20 · due 5mo ago Pending
  5. T+60 · due 3mo ago Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three C-suite insiders at KalVista (CEO, CMO, CDO) sold a combined $87K in open-market sales on May 18, 2026, at $26.76/share. This follows a separate cluster of CMO and CFO sales on May 21-22 totaling $112K, including derivative exercises. Total insider selling of ~$199K over 7 days is modest relative to the $1.4B market cap (0.014%), but the cluster involves the CEO and multiple senior executives, which is notable for a pre-commercial biotech awaiting a pivotal catalyst.

Key Financial Metrics

Direction
selling
Total Value
$87.0K
Insiders
3

Key Facts

  • CEO Benjamin Palleiko sold 1,100 shares for $30K on May 18
  • CMO Paul Audhya sold 1,000 shares for $28K on May 18, plus 2,685 shares for $72K on May 22
  • CDO Christopher Yea sold 1,100 shares for $30K on May 18
  • CFO Brian Piekos sold 1,489 shares for $40K on May 22
  • Total open-market sales in cluster: $87K (0.006% of market cap)
  • Combined with prior 5-day cluster: ~$199K total insider sales (0.014% of market cap)
  • CMO and CFO also exercised stock options (non-cash) on May 21
  • KalVista is a pre-revenue biotech with a $1.4B market cap, awaiting sebetralstat (hereditary angioedema) catalyst

Financial Impact

Total insider sales of ~$199K, or 0.014% of $1.4B market cap, economically trivial in absolute terms

insider ownershipmarket sentiment

Risk Factors

  • Insider sales may be 10b5-1 plan-driven or for tax/estate planning, not informational
  • Dollar amount is tiny relative to market cap, could be routine portfolio rebalancing
  • Pre-commercial biotech stock prices are driven by pipeline catalysts, not insider trading patterns

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-KALV-1779838419890

Track record

12 reports on KALV

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +4.15% at T+5 after the Apr 17, 2026 report. 2 of 5 went positive at some point.

Filters
  1. Jun 22, 202621w ago 15-12G Bearish 7/10 No price data
  2. Jun 17, 202621w ago EFFECT Neutral 3/10 Entry $27.00 No price data
  3. Jun 11, 202622w ago 8-K Neutral 5/10 Entry $26.99 No price data
  4. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $27.00 No price data
  5. May 19, 202625w ago Insider Cluster Bearish 5/10 Viewing Entry $26.81 to $26.79 ▲ +0.07% +1.31% vs SPY
  6. May 19, 202625w ago Insider Cluster Neutral 2/10 Entry $26.81 to $26.79 ▼ −0.07% −1.31% vs SPY
  7. Apr 29, 202628w ago 8-K Bullish 8/10 Entry $26.67 to $26.71 ▲ +0.15% −2.96% vs SPY
  8. Apr 17, 202630w ago Insider Cluster Bearish 6/10 Entry $20.48 to $19.63 ▲ +4.15% +4.71% vs SPY
  9. Feb 23, 202638w ago Insider Cluster Bearish 6/10 Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
  10. Feb 23, 202638w ago Insider Cluster Bearish 7/10 Entry $15.56 to $16.06 ▼ −3.21% −2.59% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 26, 2026